A Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma
Stopped Difficulties in recruiting patients due to changing in treatment standards for the target population
Conditions
- Eye Cancer, Retinoblastoma
Interventions
- DRUG: Topotecan
- DRUG: Melphalan
Sponsor
Prof. Beck Popovic Maja